- Home
- NVAX vs EXTR Comparison
NVAX vs EXTR Comparison
Compare NVAX & EXTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- EXTR
- Stock Information
- Founded
- NVAX 1987
- EXTR 1996
- Country
- NVAX United States
- EXTR United States
- Employees
- NVAX N/A
- EXTR N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- EXTR Telecommunications Equipment
- Sector
- NVAX Health Care
- EXTR Telecommunications
- Exchange
- NVAX Nasdaq
- EXTR Nasdaq
- Market Cap
- NVAX 1.3B
- EXTR 2.6B
- IPO Year
- NVAX 1995
- EXTR 1999
- Fundamental
- Price
- NVAX $8.39
- EXTR $22.26
- Analyst Decision
- NVAX Buy
- EXTR Strong Buy
- Analyst Count
- NVAX 7
- EXTR 6
- Target Price
- NVAX $14.29
- EXTR $21.42
- AVG Volume (30 Days)
- NVAX 6.8M
- EXTR 1.3M
- Earning Date
- NVAX 11-11-2025
- EXTR 10-29-2025
- Dividend Yield
- NVAX N/A
- EXTR N/A
- EPS Growth
- NVAX N/A
- EXTR N/A
- EPS
- NVAX 2.54
- EXTR N/A
- Revenue
- NVAX $1,078,718,000.00
- EXTR $1,140,067,000.00
- Revenue This Year
- NVAX $61.69
- EXTR $10.26
- Revenue Next Year
- NVAX N/A
- EXTR $7.48
- P/E Ratio
- NVAX $3.30
- EXTR N/A
- Revenue Growth
- NVAX 9.22
- EXTR 2.05
- 52 Week Low
- NVAX $5.01
- EXTR $10.10
- 52 Week High
- NVAX $15.22
- EXTR $22.89
- Technical
- Relative Strength Index (RSI)
- NVAX 56.61
- EXTR 61.39
- Support Level
- NVAX $7.83
- EXTR $22.10
- Resistance Level
- NVAX $8.31
- EXTR $22.70
- Average True Range (ATR)
- NVAX 0.38
- EXTR 0.61
- MACD
- NVAX 0.05
- EXTR -0.05
- Stochastic Oscillator
- NVAX 74.84
- EXTR 72.61
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About EXTR Extreme Networks Inc.
Extreme Networks Inc provides AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. The group designs, develops, and manufactures wired, wireless, and software-defined wide area network (SD-WAN) infrastructure equipment. It has one reportable segment, the development, marketing, and sale of network infrastructure equipment and related software. The Company operates in three geographical areas: Americas, EMEA, and APAC.